AI 본문요약

엑셀 다운로드 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

참고문헌 (32)

1. Pillai MRA, Chakraborty S, Das T, Venkatesh M, Ramamoorthy N. Production logistics of $^{177}Lu$ for radionuclide therapy. Appl Radiat and Isoto 2003;59:109-18 

   상세보기

2. Volkert WA, Goeckeler WF, Ehrhardt, GJ, Ketring AR. Therapeutic radionuclides: production and decay property considerations. J Nucl Med 1991;32:174-85 

3. Wessels BW, Rogus RD. Radionuclide selection and model absorbed dose calculations for radiolabelled tumor associated antibodies. Med Phys 1984;11:638-45 

   상세보기

4. Fritzberg AR, Gustavson LM, Hylarides MD, Reno JM. Chemical and Stuctural Approaches to Rational Drug Design. Boca Raton 1995;125 

5. Volkert WA, Hoffman TJ. Therapeutic radiophamaceuticals. Chem Rev 1999;99:2269-92 

   상세보기

6. Qaim SM. Therapeutic radionuclides and nuclear data. Radiochim Acta 2001;89:297-302 

   상세보기

7. Srivastava SC, Dadachova E. Recent advances in radionuclide therapy. Semin Nucl Med 2001;31:330-41 

   상세보기

8. Ehrhardt GJ, Ketring AR, Ayers LM. Reactor produced radionuclides at the University of Missouri research reactor. Appl Radiat Isot 1998;49:295-7 

   상세보기

9. Mausner LF, Kolsky KL, Joshi V, Srivastava SC. Radionuclide development at BNL for nuclear medicine therapy. Appl Radiat Isot 1998;49:285-94 

   상세보기

10. Mausner LF, Srivastava SC. Selection of radionuclides for radioimmunotherapy. Med Phys 1993;20:503-9 

    상세보기

11. Kamioski H, Mirzadeh S, Lambrecht RM, Knapp Jr. R, Dadachova K. $^{188}$ Re generator for biomedical applications. Radiochim Acta 1994;65:39-46 

    상세보기

12. Grazman B, Troutner DE. $^{105}$ Rh as a potential radiotherapeutic agent. Appl Radiat Isot 1988;39:257-60 

    상세보기

13. Unni PR, Pillai MRA. Preparation and radiochemical separation of Rh-105 for radiopharmaceutical applications. Radiochim Acta 2002;90:363-9 

    상세보기

14. Venkatesh M, Pandey U, Dhami PS, Kannan R, Achuthan PV, Chitnis RR, et al. Complexation studies with 90Y from a novel 90Sr-90Y generator. Radiochim Acta 2001;89:413-7 

    상세보기

15. Rogers BE, Anderson CJ, Connett JM. Comparison of bifunctional chelates for radiolabeling monoclonal antibodies withcopper radioisotopes: biodistribution and metabolism. Bioconj Chem 1996;7:511-22 

    상세보기

16. O'Brien Jr. HA. The preparation of $^{67}$ Cu from $^{67}$ Zn in a nuclear reactor. Int J Appl Radiat Isot 1969;20:121-4 

    상세보기

17. O'Donoghue JA, Bardies M, Wheldon TE. Relationships between tumor size and curability for uniformly targeted therapy with betaemitting radionuclides. J Nucl Med. 1995;36:1902-9 

    상세보기

18. O'Donoghue JA. Dosimetric aspects of radioimmunotherapy. Tumor Targeting 1998;3:105-11 

19. Carlsson J, Aronsson EF, Gietala SO, Stigbrand T, Tennvall J.Tumour therapy with radionuclides: assessment of progress and problems. Radiotherapy and oncol. 2003;66:107-17 

    상세보기

20. Essand M, Gronvik C, Hartman T, Carlsson J. Radioimmunotherapy of prostatic adenocarcinomas: effects of $^{131}$ I-labelled E4 antibodies on cells at different depth in DU 145 spheroids. Int J Cancer 1995;63:387-94 

    상세보기

21. Zweit J. Radionuclides and carrier molecules for therapy. Phys Med Biol 1996;41:1905-14 

    상세보기

22. Bernhardt P, Forssell-Aronsson E, Jacobsson L, Skarnemark G.Low-energy electron emitters for targeted radiotherapy of small tumours. Acta Oncol 2001;40:602-8 

    상세보기

23. Larsen RH, Murud KM, Akabani G, Hoff P, Bruland OS, Zalutsky MR. $^{211}$ At- and $^{131}$ I-labeled bisphosphonates with high in vivo stability and bone accumulation. J Nucl Med 1999;40:1197-203 

24. McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, Wu K, Pellegrini V, Curcio MJ, Miederer M, Bander NH, Scheinberg DA. Tumor therapy with targeted atomic nanogenerators. Science 2001;294:1537-41 

    상세보기

25. Palm S, Back T, Claesson I, Delle U, Hultborn R, Jacobsson L, Kopf I, Lindegren S. Effects of the alpha-particle emitter At-211 and low-dose-rate gamma-radiation on the human cell line Colo-205 as studied with a growth assay. Anticancer Res 1998;18:1671-6 

    상세보기

26. Yao Z, Garmestani K, Wong KJ, Park LS, Dadachova E, Yordanov A, Waldmann TA, Eckelman WC, Paik CH, Carrasquillo JA. Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody. J Nucl Med 2001;42:1538-44 

    상세보기

27. Zalutsky MR, Vaidyanathan G. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy. Curr Pharm Des 2000;6:1433-55 

    상세보기

28. Hofer KG. Biophysical aspects of Auger processes. Acta Oncol 2000;39:651-8 

    상세보기

29. O'Donoghue JA, Wheldon TE. Targeted radiotherapy using Auger electron emitters. Phys Med Biol 1996;41:1973-92 

    상세보기

30. Jean-Francois Chatal, Cornelis A Hoefnagel. Radionuclide therapy. Lancet 1999;354:931-5 

    상세보기

31. Teunissen JJM, Kwekkeboom DJ, Jong M, Esser JP, Valkema R, Krenning EP. Peptide receptor radionuclide therapy. Best Practice & Research Clinical Gastroenterology 2005;19:595-616 

    상세보기

32. Pietzsch HJ, Gupta A, Reisgys M, Drews A, Seifert S, Syhre R, et al. Chemical and Biological Characterization of Technetium (I) and Rhenium(I) Tricarbonyl Complexes with Dithioether Ligands Serving as Linkers for Coupling the $Tc(CO)_{3}$ and $Re(CO)_{3}$ Moieties to Biologically Active Molecules. Bioconjugate Chem. 2000;11:414-24 

    상세보기

저자의 다른 논문 :

최선주 (10) 홍영돈 (8) 이소영 (1)